Strategic minority stake in Malaysia’s pharmaceutical firm Ain Medicare acquired by Ekuinas
Ekuiti Nasional Berhad (Ekuinas) declared that it had invested in Ain Medicare Sdn Bhd, a Bumiputera-owned company that produces sterile parenteral medications.
According to a statement from Ekuinas, the investment was made using MYR 1 billion ($790 million). Ekuinas will obtain a strategic minority stake in the business through the Tranche IV fund.
This is in line with Ekuinas’ mission to grow Bumiputera businesses in key industries that support Malaysia’s long-term economic stability.
“Recognizing healthcare as a priority industry for Ekuinas, the pharmaceuticals subsector plays a key role in higher-value industrial growth and national resilience,
“Ain Medicare has established itself as a homegrown leader in sterile parenteral products, with a proven 30-year track record,
diversified customer base and strong research and development pipeline,” said Aliff Omar Mohamad Omar, Chief Executive Officer of Ekuinas.
According to him, the pharmaceutical sector in Malaysia is expected to grow at a rate of about 6.4 percent per year to reach over MYR 15 billion ($11.77 billion) by 2030, reflecting changes in the country’s population, growing healthcare demand, and improved domestic manufacturing capabilities.
He pointed out that the pharmaceutical industry is becoming more widely acknowledged as a strategic sector that supports supply security, economic resilience, and higher-value industrial development due to the nation’s emphasis on and advancements in this field.
“Institutional capital has an important role in supporting the growth of scalable local players within priority industries,
“The sector’s long-term fundamentals, underpinned by regulatory strengthening, export expansion and innovation in specialized products, present sustainable growth opportunities while contributing meaningfully to Malaysia’s broader economic aspirations,” he added.
In the end, he claimed that this investment highlights the significance of strategic alliances and cooperation between government-affiliated investment funds and the companies that make up their portfolio in order to create robust, competitive, and future-ready Malaysian businesses.
In line with Ekuinas’ goal of creating leading, scalable Bumiputera businesses, Rick Ramli, Non-Independent Non-Executive Director of Ekuinas and Deputy President and Group Chief Executive of Permodalan Nasional Berhad (PNB), stated that this investment shows a persistent dedication to bolstering Bumiputera participation in strategic sectors.
“Ain Medicare’s journey exemplifies the ‘Bumiputera Relay Race’ in action, having been supported by VentureTECH from 2017 to 2025 to strengthen its operational capabilities and scale its manufacturing capacity, before progressing to its next phase with Ekuinas,” he added.
